GENMAB AS SP.ADR/1/10DK 1 (GE91) — Free Cash Flow Generation Index
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of €288.00 Million represents 1% of operating cash flow (€301.00 Million). Read GENMAB AS SP.ADR/1/10DK 1 (GE91) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GENMAB AS SP.ADR/1/10DK 1 Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for GENMAB AS SP.ADR/1/10DK 1 across 5 annual periods. Explore GENMAB AS SP.ADR/1/10DK 1 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
Year-by-year Free Cash Flow Generation Index for GENMAB AS SP.ADR/1/10DK 1. For the full company profile including market capitalisation, see GE91 market cap overview.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | €1.13 Billion | €1.19 Billion | €55.00 Million | ▼ -0.8% |
| 2024 | 0.96x | €1.04 Billion | €1.08 Billion | €42.41 Million | ▲ +1.2% |
| 2023 | 0.95x | €1.04 Billion | €1.10 Billion | €55.83 Million | ▲ +3.3% |
| 2022 | 0.92x | €517.42 Million | €563.05 Million | €45.63 Million | ▲ +3.6% |
| 2021 | 0.89x | €300.82 Million | €339.18 Million | €38.36 Million | — |